Related Experiment Videos
Infectious complications in neutropenic patients. Clinical-laboratory correlations
D J Melewski1, D J Higby, P A Reese
1Department of Medical Oncology, Roswell Park Memorial Institute, Buffalo, NY 14263.
Journal of Medicine
|January 1, 1988
Summary
Infection outcomes in leukemia patients can be predicted by measuring C3 complement and C-reactive protein (CRP) levels. Serial measurements of total complement (TC), C3, and CRP may improve prediction of infection treatment success.
Area of Science:
- Immunology
- Hematology
- Infectious Disease
Background:
- Bone marrow transplantation and acute non-lymphocytic leukemia (ANLL) treatment often lead to neutropenia, increasing infection risk.
- Monitoring immune markers is crucial for assessing infection outcomes in immunocompromised patients.
Purpose of the Study:
- To investigate the relationship between infection outcomes (survival/death) and specific immune markers in ANLL patients.
- To determine if total complement (TC), complement components (C3), or C-reactive protein (CRP) levels predict infection prognosis.
Main Methods:
- Serum samples were collected from 34 ANLL patients during febrile episodes.
- Measurements included total complement (TC), C3 complement component, and C-reactive protein (CRP).
- Multivariate logistic regression analyzed the correlation between immune markers and infection outcome.
Main Results:
- Significant differences in final TC, C3, and CRP levels were observed between survivors and non-survivors.
- Final C3 complement and CRP levels were significantly associated with infection outcome.
- Changes in these markers from initial to final measurements also predicted patient outcome.
Conclusions:
- C3 complement and CRP levels are significant predictors of infection outcome in ANLL patients.
- Serial monitoring of TC, C3, and CRP may offer enhanced predictive value for infection management.
- These markers can potentially assist clinicians in evaluating the efficacy of antibiotic therapies.